Medical Policies
Home
Search Bar
Category Filter
Policies & Guidelines
Behavioral Health
Chronic Condition Management
Hemophilia Drugs
Draft Hemophilia Drug Policies
Final Hemophilia Drug Policies
Hemophilia Drug Prior Authorization
Medical Policies
Draft Medical Policies
Final Medical Policies
Pre-Service Review (Precertification and Predetermination)
Provider-Administered Drug Policies
Draft Provider-Administered Drug Policies
Final Provider-Administered Drug Precertification Policies
Mandatory Site of Service
Provider-Administered Drug Claim Edit Policies
Voluntary Site of Service
Self-Administered Drug Policies
Draft Self-Administered Drug Policies
Final Self-Administered Drug Policies
Self-Administered Drug Prior Authorization Forms
Asset Publisher
< Back to Final Medical Policies page
Final Policies - Laboratory
Policy #
Policy Title
Print View
MP-062
High Sensitivity C-Reactive Protein
MP-063
Fetal Fibronectin Enzyme Immunoassay
MP-071
Allergy Testing
MP-096
Antiprothrombin Antibody
MP-142
B-Natriuretic Peptide
MP-155
Measurement of Lipoprotein-Associated Phospholipase A2 in the Assessment of Cardiovascular Risk
MP-161
Serologic Diagnosis of Celiac Disease
MP-165
Antigen Leukocyte Antibody Test
MP-195
Serum Tumor Markers for Breast and Gastrointestinal Malignancies
MP-196
End-Tidal Carbon Monoxide Measurement (ETCOc)
MP-200
Evaluation of Biomarkers for Alzheimer Disease
MP-239
Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor
MP-264
HIV Genotyping and Phenotyping
MP-285
Serum Antibodies for the Diagnosis of Inflammatory Bowel Disease
MP-322
Laboratory Testing for HIV Tropism
MP-341
Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disease
MP-353
Anti-CCP Testing for Rheumatoid Arthritis
MP-378
Intracellular Micronutrient Analysis
MP-393
Bone Turnover Markers for the Diagnosis and Management of Osteoporosis and Diseases Associated With High Bone Turnover
MP-407
Fecal Analysis in the Diagnosis of Intestinal Dysbiosis
MP-426
Multi-marker Serum-Testing Related to Ovarian Cancer
MP-428
Systems Pathology in Prostate Cancer
MP-445
Serum Biomarker Human Epididymis Protein 4 (HE4)
MP-448
Serum Holotranscobalamin as a Marker of Vitamin B12 (Cobalamin) Status
MP-472
Fecal Calprotectin Testing
MP-510
Measurement of Serum Antibodies to Selected Biologic Agents
MP-513
Genetic Testing for Hereditary Breast and/or Ovarian Cancer
MP-545
Human Leukocyte Antigen (HLA) Testing for Celiac Disease
MP-548
Identification of Microorganisms Using Nucleic Acid Probes
MP-562
Multianalyte Assays With Algorithmic Analyses for Predicting Risk of Type 2 Diabetes
MP-563
Serum Biomarker Tests for Multiple Sclerosis
MP-564
Biomarker and Disease Activity Testing for Rheumatoid Arthritis
MP-565
Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases
MP-566
Drug Testing
MP-567
Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease
MP-570
Proteomic Testing for Systemic Therapy in Non-Small Cell Lung Cancer
MP-584
Fecal Microbiota Transplantation
MP-592
Laboratory Tests for Chronic Heart Failure and Heart Transplant Rejection
MP-613
Nutrient/Nutritional Panel Testing
MP-707
Protein Biomarkers for Diagnosis and Risk Assessment of Prostate Cancer
MP-711
Plasma-Based Proteomic Screening of Pulmonary Nodules
MP-746
Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes
MP-758
Multitarget Polymerase Chain Reaction Testing for Diagnosis of Bacterial Vaginosis
Hidden